Universal Ibogaine Inc. (IBOGF)
OTCMKTS · Delayed Price · Currency is USD
0.0063
+0.0003 (4.50%)
Nov 5, 2025, 11:54 AM EST
Universal Ibogaine Market Cap
Universal Ibogaine has a market cap or net worth of $1.11 million as of November 5, 2025. Its market cap has decreased by -67.91% in one year.
Market Cap
1.11M
Enterprise Value
2.85M
Revenue
1.49M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.01
Market Cap Chart
Since October 5, 2021, Universal Ibogaine's market cap has decreased from 27.27M to 1.11M, a decrease of -95.92%. That is a compound annual growth rate of -54.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 3, 2025 | 1.11M | 3.75% |
| Dec 31, 2024 | 1.07M | 47.59% |
| Dec 28, 2023 | 726.62K | -65.76% |
| Dec 30, 2022 | 2.12M | -88.73% |
| Dec 31, 2021 | 18.82M | -30.97% |
| Oct 5, 2021 | 27.27M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 815.18M |
| Elite Pharmaceuticals | 654.92M |
| Glass House Brands | 582.61M |
| Northwest Biotherapeutics | 386.96M |
| Nika Pharmaceuticals | 311.89M |
| CytoDyn | 311.61M |
| Silence Therapeutics | 307.49M |
| American Oncology Network | 307.04M |